What is the recommended management of hypoglycemia in adults and children?

Management of Hypoglycemia in Adults and Children

For conscious patients with blood glucose ≤70 mg/dL (3.9 mmol/L), immediately administer 15-20 g of glucose tablets or other fast-acting carbohydrates, recheck glucose in 15 minutes, and repeat treatment if hypoglycemia persists; for unconscious patients or those unable to swallow, administer glucagon immediately (or intravenous glucose if available). 1, 2

Immediate Treatment Algorithm

For Conscious Patients (Mild to Moderate Hypoglycemia)

Blood Glucose Thresholds:

• Alert value: ≤70 mg/dL (3.9 mmol/L) - initiate treatment 2
• Clinically significant: <54 mg/dL (3.0 mmol/L) - urgent treatment required 2

Treatment Steps:

1. Administer 15-20 g of fast-acting carbohydrate 1:

   • Glucose tablets are preferred over dietary sugars (fruit juice, regular soda, hard candy) as they provide faster symptom resolution 1, 3
   • For younger children, reduce dose to 10 g 4
   • For moderate hypoglycemia requiring assistance, use 20-30 g of glucose 4

2. Wait 15 minutes and recheck blood glucose 1

3. If hypoglycemia persists, repeat the 15-20 g carbohydrate dose 1

4. Once glucose normalizes, consume a meal or protein-containing snack to prevent recurrence 4, 2

Critical Caveat for α-Glucosidase Inhibitor Users:

• If taking acarbose or similar medications, use only monosaccharides (glucose tablets) - not table sugar or complex carbohydrates, as the drug blocks their digestion 1

For Unconscious Patients or Those Unable to Swallow (Severe Hypoglycemia)

Severe hypoglycemia is defined as altered consciousness, coma, seizures, or inability to self-treat 4, 2, 4

Treatment Options:

1. Glucagon administration (preferred for non-medical settings) 4, 2, 4:

   • Dose for children: 30 mcg/kg subcutaneously (maximum 1 mg) 4
   • Dose for adults: 1 mg subcutaneously or intramuscularly 2
   • Newer formulations not requiring reconstitution are strongly preferred over traditional glucagon kits for ease of use 5, 6
   • Expect blood glucose rise within 5-15 minutes, though nausea and vomiting may occur 4
   • Lower doses (10 mcg/kg) cause less nausea but similar 20-minute glucose levels 4

2. Intravenous glucose (if in medical facility) 7, 4:

   • Administer IV glucose immediately for hospitalized patients 7
   • Switch to oral glucose once patient regains consciousness 7

3. After recovery, provide oral carbohydrates when patient can safely swallow 7, 2

Special Populations and Contexts

Perioperative/Hospitalized Patients

Monitoring Requirements:

• Measure capillary blood glucose with any symptom suggestive of hypoglycemia 7
• Increase monitoring frequency for patients on insulin or insulin secretagogues due to hypoglycemia unawareness 7

Treatment Thresholds:

• <60 mg/dL (3.3 mmol/L): Administer glucose immediately, even without symptoms 7
• 70-100 mg/dL (3.8-5.5 mmol/L) with symptoms: Administer glucose if patient reports hypoglycemic symptoms 7

Route Selection:

• Prefer oral route when patient is conscious 7
• Use IV glucose for unconscious patients or those unable to swallow 7

Patients on Insulin Therapy

Prevention Strategies:

• For multiple daily injections or pump users: Lower mealtime insulin dose if physical activity occurs within 1-2 hours of injection 1
• For premixed insulin users: Never skip meals; maintain consistent meal timing 1
• For fixed insulin regimens: Eat similar carbohydrate amounts daily to match insulin doses 1
• Always carry fast-acting carbohydrate source during physical activity 1

Alcohol Considerations:

• Consume alcohol with food to reduce hypoglycemia risk (limit: ≤1 drink/day for women, ≤2 drinks/day for men) 1

Prevention and Long-Term Management

Education and Monitoring

Essential Patient Education:

• All individuals at risk should receive structured diabetes education programs, which reduce severe hypoglycemia episodes and time below 54 mg/dL 5, 8
• Teach recognition of hypoglycemia symptoms: sweating, pallor, palpitations, tremors, headache, confusion, behavior changes 4
• Educate family members, caregivers, and school personnel on glucagon administration 2, 6

Technology Utilization:

• Continuous glucose monitoring (CGM) should be initiated early in type 1 diabetes to improve outcomes and minimize hypoglycemia 9, 5, 8
• CGM reduces severe hypoglycemia episodes and time spent <54 mg/dL in both type 1 and type 2 diabetes 5, 8
• Automated insulin delivery systems should be offered to all adults with type 1 diabetes 9

Medication Adjustments

When Hypoglycemia Occurs:

• Reevaluate treatment regimen immediately after hypoglycemia unawareness or severe hypoglycemia episodes 2
• Raise glycemic targets for several weeks to reverse hypoglycemia unawareness and reduce future risk 2
• Consider switching to long-acting insulin analogs, which are associated with less hypoglycemia than NPH insulin 5, 8

Glucagon Prescribing:

• Prescribe glucagon for all individuals at increased risk of blood glucose <54 mg/dL 2
• Ensure it is readily available at home, school, and work 10, 2

Common Pitfalls to Avoid

1. Do not use complex carbohydrates or dietary sugars in patients taking α-glucosidase inhibitors - only glucose tablets work 1

2. Do not delay glucagon administration in severe hypoglycemia waiting for IV access - subcutaneous/intranasal glucagon can be life-saving 4, 2, 6

3. Do not assume bedtime glucose predicts nocturnal hypoglycemia - it is a poor predictor; consider CGM for detection 4

4. Do not ignore mild hypoglycemia - repeated episodes lead to hypoglycemia unawareness and defective counterregulation 4, 11

5. Do not forget the follow-up meal/snack after treating hypoglycemia - prevents recurrence 4, 2

6. Do not use traditional glucagon kits requiring reconstitution when newer ready-to-use formulations are available - they are easier for caregivers to administer correctly 5, 6